title: Dose selection in phase I studies: why we should always go for the top.
authors.forename: Stefan
authors.initials: S
authors.lastname: Sleijfer
authors.forename: Erik
authors.initials: E
authors.lastname: Wiemer
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017321:Clinical Trials, Phase I as Topic / Q000379:methods*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D020714:Maximum Tolerated Dose; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents